PMEF
CLPT icon

Point72 Middle East FZE’s ClearPoint Neuro CLPT Stock Holding History

Point72 Middle East FZE’s Portfolio CLPT Stock Details CLPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-3,547
Closed -$29.9K – 1604
2023
Q1 		$29.9K Buy
+3,547
New +$31.1K ﹤0.01% 1365

Other funds holding CLPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TFCM
Taylor Frigon Capital Management Scottsdale, Arizona $176M AUM 24.25% 1-Year Est. Return
SL
Sentinus LLC Oak Brook, Illinois $1.11B AUM 17.13% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
CWM
Cahill Wealth Management Portage, Michigan $196M AUM 8.5% 1-Year Est. Return
CM
CM Management Gulf Breeze, Florida $120M AUM 37.12% 1-Year Est. Return

Point72 Middle East FZE's CLPT Position: Q2 2023 in Review

Point72 Middle East FZE sold out of ClearPoint Neuro (CLPT) in Q2 2023, closing a stake of 3,547 shares — an estimated $29.9K sold.

Point72 Middle East FZE first reported a position in CLPT in Q1 2023 and held it in 1 quarter. The position peaked at $29.9K in Q1 2023. 60 funds tracked by Wall St. Rank hold CLPT as of Q2 2023.

  • Point72 Middle East FZE reported no remaining ClearPoint Neuro position as of Q2 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 3,547 ClearPoint Neuro shares in Q2 2023, an estimated $29.9K.
  • Point72 Middle East FZE first reported a position in ClearPoint Neuro in Q1 2023 and held it in 1 quarter.
  • Point72 Middle East FZE's ClearPoint Neuro position peaked at $29.9K in Q1 2023.
  • 60 funds tracked by Wall St. Rank held ClearPoint Neuro as of Q2 2023.

Based on Point72 Middle East FZE's 13F filing for Q2 2023, filed 14 Aug 2023.